Loading...
XLON
ZTF
Market cap204mUSD
Jul 14, Last price  
310.00GBP
1D
-1.90%
1Q
24.50%
Jan 2017
24.00%
Name

Zotefoams PLC

Chart & Performance

D1W1MN
XLON:ZTF chart
No data to show
P/E
1,647.36
P/S
119.90
EPS
0.19
Div Yield, %
2.35%
Shrs. gr., 5y
1.15%
Rev. gr., 5y
9.40%
Revenues
127m
-0.31%
25,176,00027,975,00030,052,00031,606,00034,781,00031,816,00039,879,00044,208,00047,188,00044,634,00048,945,00053,869,00057,376,00070,146,00081,037,00080,860,00082,652,000100,750,000127,369,000126,975,000
Net income
9m
-7.64%
1,170,0002,427,0001,239,0002,918,0003,006,0002,164,0004,352,0004,497,0004,728,0003,161,0003,336,0004,824,0005,795,0006,008,0007,852,0008,217,0007,163,0004,376,00010,006,0009,242,000
CFO
8m
-63.17%
4,487,0003,197,0003,767,0004,077,0005,004,0005,808,0006,157,0004,979,0005,258,0005,596,0005,054,0007,533,0005,170,0008,732,0004,492,0008,466,00010,858,00010,897,00021,124,0007,781,000
Dividend
Sep 05, 20242.38 GBP/sh

Profile

Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, Continental Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand. The company also provides T-FIT, a clean insulation system that is used in the pharmaceutical, biotech, and semiconductor cleanroom industries. In addition, it owns and licenses patented MuCell microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was founded in 1921 and is headquartered in Croydon, the United Kingdom.
URL
https://www.zotefoams.com/
IPO date
Feb 21, 1995
Employees
580
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
126,975
-0.31%
127,369
26.42%
Cost of revenue
111,840
113,012
Unusual Expense (Income)
NOPBT
15,135
14,357
NOPBT Margin
11.92%
11.27%
Operating Taxes
3,598
2,217
Tax Rate
23.77%
15.44%
NOPAT
11,537
12,140
Net income
9,242
-7.64%
10,006
128.66%
Dividends
(3,350)
(3,188)
Dividend yield
2.01%
1.89%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
37,034
37,955
Long-term debt
2,161
908
Deferred revenue
(1)
Other long-term liabilities
2,656
3,290
Net debt
32,694
27,994
Cash flow
Cash from operating activities
7,781
21,124
CAPEX
(5,744)
(7,092)
Cash from investing activities
(8,292)
(7,092)
Cash from financing activities
(3,725)
(11,526)
FCF
1,363
9,155
Balance
Cash
6,294
10,594
Long term investments
207
275
Excess cash
152
4,501
Stockholders' equity
66,898
65,365
Invested Capital
156,128
146,510
ROIC
7.62%
8.43%
ROCE
9.37%
9.27%
EV
Common stock shares outstanding
49,805
49,539
Price
3.35
-1.47%
3.40
-15.42%
Market cap
166,847
-0.94%
168,433
-15.07%
EV
199,541
196,427
EBITDA
23,352
22,601
EV/EBITDA
8.54
8.69
Interest
2,540
1,738
Interest/NOPBT
16.78%
12.11%